Biopharmaceutical drugs offer new therapeutic solutions to numerous human diseases and conditions. However, these advanced therapies come with the risk of efficacy loss due to protein interactions, which can potentially lead to immunogenicity and impact the patient’s safety and therapeutic outcome. Addressing these challenges is critical for maintaining the effectiveness and safety of biopharmaceutical treatments.
Terumo’s PLAJEX™ pre-fillable syringes (PFS) are specifically designed to meet the needs of a wide variety of drugs, including those requiring low reactive containers. In this presentation at the 2022 Nelson Labs Virtual Symposium, we will highlight the key advantages of PLAJEX™ PFS and the extensive experience Terumo has built over two decades of processing primary containers on their fill-and-finish lines in Japan.
The session will provide a detailed overview of the unique features and benefits of PLAJEX™ PFS, demonstrating how these syringes help mitigate the risk of protein interactions and immunogenicity. Participants will learn about the materials and design considerations that make PLAJEX™ PFS an ideal choice for sensitive biopharmaceutical formulations.
Additionally, the presentation will cover Terumo’s experience and expertise in processing these primary containers, ensuring high-quality standards and reliability. By sharing insights from their extensive operational history, Terumo will illustrate the practical applications and performance of PLAJEX™ PFS in real-world settings.
This webinar is essential for professionals involved in the development, manufacturing, and quality assurance of biopharmaceutical drugs. Attendees will gain valuable knowledge about the importance of selecting appropriate primary containers and the benefits of using PLAJEX™ PFS to enhance drug stability and patient safety.